논문 상세보기

Regulation of Bcl-2 Family Protein Changes by Chlorogenic Acid Treatment in Focal Cerebral Ischemia of Rats KCI 등재

Ju Bin Kang, Myeong Ok Kim, Phil Ok Koh
  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/434928
구독 기관 인증 시 무료 이용이 가능합니다. 4,200원
농업생명과학연구 (Journal of Agriculture & Life Science)
경상국립대학교 농업생명과학연구원 (Institute of Agriculture & Life Science, Gyeongsang National University)
초록

Ischemic stroke is a high mortality disease that causes irreversible damage. Chlorogenic acid is a polyphenolic substance with neuroprotective properties. Bcl-2 family proteins perform a critical role in apoptosis process. Bcl-2 and Bcl-xL are anti-apoptotic proteins that prevent cell death, and Bax and Bad are pro-apoptotic proteins that promote apoptosis. We investigated whether chlorogenic acid modulates Bcl-2 family proteins during focal cerebral ischemia. We made a rat model of ischemic stroke by performing middle cerebral artery occlusion (MCAO). Chlorogenic acid (30 mg/kg) or phosphate-buffered saline was treated via intraperitoneal injection 2 hr before MCAO. Neurological behavioral tests were performed 24 hr after MCAO damage and cortical tissues were collected. Reverse transcription-PCR, Western blot, and immunofluorescence staining were performed to observe changes in Bcl-2 family proteins expression. MCAO-damage induced neurobehavioral disorders and chlorogenic acid alleviate these deficits. Bcl-2 and Bcl-xL expressions were decreased and Bax and Bad expressions were increased in MCAO animals. However, chlorogenic acid treatment attenuated the decrease of Bcl-2 and Bcl-xL and the increase of Bad and Bax due to MCAO surgery. Moreover, chlorogenic acid treatment attenuated MCAO-induced upregulation of caspase-3. These findings suggest that chlorogenic acid exerts neuroprotective effects against MCAO damage by regulating Bcl-2 family proteins including Bcl-2, Bcl-xL, Bax, and Bad.

키워드
Bcl-2 family proteinChlorogenic acidIschemic strokeNeuroprotection
목차
Introduction
Materials and Methods
    1. Experimental animals and drug treatment
    2. Middle cerebral artery occlusion (MCAO)
    3. Neurological deficit scoring test
    4. Corner test
    5. Reverse transcription-polymerase chain reaction(RT-PCR)
    6. Western blot analysis
    7. Immunofluorescence staining
    8. Statistical analysis
Results and Discussion
    1. Neuroprotective effect of chlorogenic acid inMCAO animals
    2. Regulation mRNA expression of Bcl-2 familyproteins by chlorogenic acid in MCAO animals
    3. Regulation of Bcl-2 family proteins by chlorogenicacid in MCAO animals
    4. Modulation of caspase-3 protein expression bychlorogenic acid in MCAO animals
Acknowledgements
References
저자
  • Ju Bin Kang(Graduate Student, Department of Veterinary Anatomy and Histology, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, Jinju-daero 501, Jinju 52828, Korea)
  • Myeong Ok Kim(Professor, Division of Life Science and Applied Life Science, College of Natural Sciences, Gyeongsang National University, jinju-daero 501, Jinju 52828, Korea) Corresponding author
  • Phil Ok Koh(Professor, Department of Veterinary Anatomy and Histology, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, Jinju-daero 501, Jinju 52828, Korea) Corresponding author